Johannes Streffer

Johannes Streffer

Auto-generated profile, based on publicly available information

Johannes Streffer

Reference Center for Biological Markers of Dementia (BIODEM), Institute Born-Bunge, University of Antwerp, Antwerp, Belgium

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2003 in Neuron
Verified
Journal Article
Closed access
CHChristoph Hock
Christoph Hock
UKUwe Konietzko
Uwe Konietzko
JSJohannes R Streffer
Johannes R Streffer
JTJay Tracy
Jay Tracy
ASAndri Signorell
Andri Signorell
RNRoger M Nitsch
Roger M Nitsch

15 October 2002 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
CHChristoph Hock
Christoph Hock
UKUwe Konietzko
Uwe Konietzko
APAndreas Papassotiropoulos
Andreas Papassotiropoulos
AWAxel Wollmer
Axel Wollmer
JSJohannes Streffer
Johannes Streffer
RNRoger M. Nitsch
Roger M. Nitsch

30 March 2004 in Molecular Psychiatry
Verified
Journal Article
Closed access
JGJürgen Götz
Jürgen Götz
JSJ R Streffer
J R Streffer
DDD David
D David
ASA Schild
A Schild
FHF Hoerndli
F Hoerndli
FCF Chen
F Chen

27 October 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
RSRuben Smith
Ruben Smith
FCFrancesca Capotosti
Francesca Capotosti
MSMartin Schain
Martin Schain
TOTomas Ohlsson
Tomas Ohlsson
EVEfthymia Vokali
Efthymia Vokali
OHOskar Hansson
Oskar Hansson
A positron emission tomography (PET) tracer detecting α-synuclein pathology will improve the diagnosis, and ultimately the treatment of α-synuclein-related diseases. Here we show that the PET ligand, [18F]ACI-12589, displays good in vitro affinity and specificity for pathological α-synuclein in tissues from patients with different α-synuclein-related disorders including Parkinson’s disease (PD) and Multiple-System Atrophy (MSA) using autoradiography and radiobinding techniques. In the initial clinical evaluation we include 23 participants with α-synuclein related disorders, 11 with other neurodegenerative disorders and eight controls. In vivo [18F]ACI-12589 demonstrates clear binding in the cerebellar white matter and middle cerebellar peduncles of MSA patients, regions known to be highly affected by α-synuclein pathology, but shows limited binding in PD. The binding statistically separates MSA patients from healthy controls and subjects with other neurodegenerative disorders, including other synucleinopathies. Our results indicate that α-synuclein pathology in MSA can be identified using [18F]ACI-12589 PET imaging, potentially improving the diagnostic work-up of MSA and allowing for detection of drug target engagement in vivo of novel α-synuclein targeting therapies.

1 January 2003 in Archives of Neurology
Verified
Journal Article
Open access
PDF file
APAndreas Papassotiropoulos
Andreas Papassotiropoulos
JSJohannes R. Streffer
Johannes R. Streffer
MTMagdalini Tsolaki
Magdalini Tsolaki
SSSimon Schmid
Simon Schmid
DTDietmar Rudolf Thal
Dietmar Rudolf Thal
CHChristoph Hock
Christoph Hock
THE CYP46 GENE encodes cholesterol 24-hydroxylase, the rate-limiting enzyme for cholesterol removal from the brain.1-3 Cholesterol 24-hydroxylase mediates the hydroxylation of brain cholesterol to 24-hydroxycholesterol that can be transported readily through the blood-brain barrier.4 Because depletion of brain cholesterol levels reduces the generation of β-amyloid peptides (Aβ),5,6 and because cholesterol-lowering drugs may reduce the risk of dementia,7,8 we tested whether polymorphisms of CYP46 are associated with brain β-amyloid load in humans by measuring the sequential pattern of β-amyloid deposition in the medial temporal lobe. Brain β-amyloid deposits contain large amounts of Aβ42. Consequently, we next tested whether CYP46 genotypes affected levels of Aβ42 in cerebrospinal fluid (CSF) obtained from patients with mild to moderate Alzheimer disease (AD).

1 June 2003 in Neurobiology of Aging
Verified
Journal Article
Closed access
MWM Axel Wollmer
M Axel Wollmer
JSJohannes R Streffer
Johannes R Streffer
DLDieter Lütjohann
Dieter Lütjohann
Magda TsolakiMagda Tsolaki
Magda Tsolaki
VIVassiliki Iakovidou
Vassiliki Iakovidou
APAndreas Papassotiropoulos
Andreas Papassotiropoulos